A-101 Topical Solution

DRUG3 trials

Sponsors

Aclaris Therapeutics, Inc.

Conditions

Common WartSeborrheic Keratosis

Phase 2

A Phase2 of A-101 Topical Solution in Subjects With Common Warts

CompletedNCT03210337

Aclaris Therapeutics, Inc.Common Wart

Start: 2017-08-01End: 2018-03-16Updated: 2019-05-01

A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts

CompletedNCT03278028

Aclaris Therapeutics, Inc.Common Wart

Start: 2017-07-13End: 2018-03-01Updated: 2019-04-09

Phase 4

An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses

CompletedNCT03487588

Aclaris Therapeutics, Inc.Seborrheic Keratosis

Start: 2018-03-21End: 2018-11-14Updated: 2019-10-02

Related Papers

Hydrogen Peroxide Topical Solution, 45% for Common Warts: Phase 2 Efficacy and Safety Trial Results.

2020-10-013 citations